97 related articles for article (PubMed ID: 437911)
41. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
[TBL] [Abstract][Full Text] [Related]
42. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
43. Significance of circulating immune complexes in pulmonary tuberculosis.
Samuel AM; Ashtekar MD; Ganatra RD
Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
[TBL] [Abstract][Full Text] [Related]
44. Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation.
Streetly M; Kazmi M; Radia D; Hoyle C; Schey SA
Bone Marrow Transplant; 2004 Jun; 33(11):1131-5. PubMed ID: 15094743
[TBL] [Abstract][Full Text] [Related]
45. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
[TBL] [Abstract][Full Text] [Related]
46. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
[TBL] [Abstract][Full Text] [Related]
47. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
48. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
49. Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefit.
Gomez GA; Reese PA; Nava H; Panahon AM; Barcos M; Stutzman L; Han T; Henderson ES
Am J Med; 1984 Aug; 77(2):205-10. PubMed ID: 6380286
[TBL] [Abstract][Full Text] [Related]
50. Circulating immune complexes in malignant melanoma: serial studies in 130 patients.
Bharwani N; Campbell L; Ashley P; Queen WD; Phillips TM; Jerry LM
Oncology; 1986; 43(3):143-8. PubMed ID: 3703459
[TBL] [Abstract][Full Text] [Related]
51. Circulating immune complexes detected by C1q solid phase assay in leprosy.
Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
[TBL] [Abstract][Full Text] [Related]
52. Circulating immune complexes in various thyroid diseases.
Brohee D; Delespesse G; Debisschop MJ; Bonnyns M
Clin Exp Immunol; 1979 Jun; 36(3):379-83. PubMed ID: 487642
[TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease.
Johansson B; Klein G; Henle W; Henle G
Int J Cancer; 1970 Nov; 6(3):450-62. PubMed ID: 4321018
[No Abstract] [Full Text] [Related]
54. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].
Loni C; Ricci S; Azzarà A; Bertoncini G
Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963
[TBL] [Abstract][Full Text] [Related]
55. Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas.
Ghalie R; Richman CM; Adler SS; Korenblit AD; Kramer TS; Manson S; Dolce A; Kaizer H
Bone Marrow Transplant; 1991 Jul; 8(1):41-5. PubMed ID: 1912954
[TBL] [Abstract][Full Text] [Related]
56. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.
Carpentier NA; Lange GT; Fiere DM; Fournie GJ; Lambert PH; Miescher PA
J Clin Invest; 1977 Oct; 60(4):874-84. PubMed ID: 268330
[TBL] [Abstract][Full Text] [Related]
57. Immunological aspects of Graves' disease patients in different clinical stages.
Gauna A; Segura G; Sartorio G; Soto R; Segal-Eiras A
J Endocrinol Invest; 1989 Nov; 12(10):671-7. PubMed ID: 2614006
[TBL] [Abstract][Full Text] [Related]
58. [Malignant lymphoma associated with HIV infection].
Mitrou PS; Serke M; Pohl C; Becker K; Schrappe-Bächer M; Knauf W; Westerhausen M; Clemens MR; Helm EB; Fischer T
Dtsch Med Wochenschr; 1991 Aug; 116(33):1217-23. PubMed ID: 1874122
[TBL] [Abstract][Full Text] [Related]
59. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
60. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]